FDA Approves New Tablet to Reduce Stroke, Heart Attack Risk
The agency approves Zontivity to reduce the risk of heart attack, stroke and cardiovascular death in high risk patients.
Read more →The agency approves Zontivity to reduce the risk of heart attack, stroke and cardiovascular death in high risk patients.
Read more →